STAT1 and carcinoma: In carcinomas, constitutive STAT3 activation also reduces the expression of ISGF3 components (such as IRF9, STAT1, and STAT2) and IRF7, a transcription factor that participates in IFN response-related gene expression by directly binding to gene promoters [79].